Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Cue Biopharma (CUE) Assets Average (2018 - 2025)

Cue Biopharma's Assets Average history spans 8 years, with the latest figure at $36.2 million for Q3 2025.

  • For Q3 2025, Assets Average fell 16.97% year-over-year to $36.2 million; the TTM value through Sep 2025 reached $36.2 million, down 16.97%, while the annual FY2024 figure was $46.9 million, 38.67% down from the prior year.
  • Assets Average for Q3 2025 was $36.2 million at Cue Biopharma, up from $31.5 million in the prior quarter.
  • Across five years, Assets Average topped out at $94.1 million in Q1 2021 and bottomed at $27.2 million in Q1 2025.
  • The 5-year median for Assets Average is $77.4 million (2023), against an average of $66.9 million.
  • The largest annual shift saw Assets Average skyrocketed 42.34% in 2021 before it plummeted 52.85% in 2025.
  • A 5-year view of Assets Average shows it stood at $81.1 million in 2021, then rose by 3.27% to $83.8 million in 2022, then decreased by 22.18% to $65.2 million in 2023, then tumbled by 40.96% to $38.5 million in 2024, then fell by 6.04% to $36.2 million in 2025.
  • Per Business Quant, the three most recent readings for CUE's Assets Average are $36.2 million (Q3 2025), $31.5 million (Q2 2025), and $27.2 million (Q1 2025).